Elysium Renewables Inc San Francisco, CA - 94117

Elysium Renewables Inc is categorized under Biological Products Manufacturers in San Francisco, CA and active since 2009.

Elysium Renewables Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.

If you are seeking more information, feel free to contact Angela Won at the company’s single location by writing to 715 Central Avenue Unit A, San Francisco, California CA 94117 or by phoning (415) 830-6513. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Elysium Renewables Inc
Contact Person: Angela Won
Address: 715 Central Avenue Unit A, San Francisco, California 94117
Phone Number: (415) 830-6513
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biological Products Manufacturers
SIC Code: 2836
NAICS Code: 325414
Share This Business:

Elysium Renewables Inc was started in 2009 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Angela Won for inquiries that concern Elysium Renewables Inc by calling the company number (415) 830-6513, as your correspondence is most welcome. Additionally, the physical location of the single location of Elysium Renewables Inc can be found at the coordinates 37.776114,-122.444987 as well as the street address 715 Central Avenue Unit A in San Francisco, California 94117.

For its online presence, you may visit Elysium Renewables Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.